China SXT Pharmaceuticals (SXTC) Shares Outstanding (Weighted Average): 2018-2025
Historic Shares Outstanding (Weighted Average) for China SXT Pharmaceuticals (SXTC) over the last 8 years, with Sep 2025 value amounting to $13.8 million.
- China SXT Pharmaceuticals' Shares Outstanding (Weighted Average) rose 4863.74% to $13.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.8 million, marking a year-over-year increase of 4863.74%. This contributed to the annual value of $3.9 million for FY2025, which is 1308.87% up from last year.
- Per China SXT Pharmaceuticals' latest filing, its Shares Outstanding (Weighted Average) stood at $13.8 million for Q3 2025, which was up 252.32% from $3.9 million recorded in Q1 2025.
- China SXT Pharmaceuticals' Shares Outstanding (Weighted Average)'s 5-year high stood at $13.8 million during Q3 2025, with a 5-year trough of $3,879 in Q1 2021.
- For the 3-year period, China SXT Pharmaceuticals' Shares Outstanding (Weighted Average) averaged around $3.1 million, with its median value being $277,276 (2024).
- Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first decreased by 0.05% in 2021, then soared by 4,863.74% in 2025.
- China SXT Pharmaceuticals' Shares Outstanding (Weighted Average) (MRQ) stood at $3,881 in 2021, then surged by 161.71% to $10,157 in 2022, then surged by 462.87% to $57,171 in 2023, then skyrocketed by 384.99% to $277,276 in 2024, then soared by 4,863.74% to $13.8 million in 2025.
- Its Shares Outstanding (Weighted Average) stands at $13.8 million for Q3 2025, versus $3.9 million for Q1 2025 and $277,276 for Q3 2024.